Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Danon

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The Lancet. Infectious Diseases|June 26, 2021
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control studyCatherine Hyams, Robin Marlow, Zandile Maseko, et al.
The Lancet Regional Health. Europe|December 19, 2022
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomCatherine Hyams, Robert Challen, Robin Marlow, et al.
Nature Communications|July 25, 2022
An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalenceMario Morvan, Anna Lo Jacomo, Celia Souque, et al.
Expert Review of Vaccines|April 3, 2020
Upper respiratory tract colonization with <i>Streptococcus pneumoniae</i> in adultsAdriano Arguedas, Krzysztof Trzciński, Katherine L O'Brien, et al.
PLOS Global Public Health|May 7, 2026
Evaluation and estimation of epidemic trajectories for SARS-CoV-2 from clinical and wastewater data in Gauteng Province, South AfricaZinhle E Mthombothi, Adrian Lison, Fiona Els, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
The Lancet Regional Health. Europe|August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort studyCatherine Hyams, Robert Challen, Elizabeth Begier, et al.
Journal of the International AIDS Society|July 24, 2018
Estimating the contribution of key populations towards the spread of HIV in Dakar, SenegalChristinah Mukandavire, Josephine Walker, Sheree Schwartz, et al.
BJGP Open|September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
The Journal of Infection|June 19, 2022
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adultsRajeka Lazarus, Christian Taucher, Claire Brown, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Lancet. Infectious Diseases|June 26, 2021
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control studyCatherine Hyams, Robin Marlow, Zandile Maseko, et al.
The Lancet Regional Health. Europe|December 19, 2022
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomCatherine Hyams, Robert Challen, Robin Marlow, et al.
Nature Communications|July 25, 2022
An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalenceMario Morvan, Anna Lo Jacomo, Celia Souque, et al.
Expert Review of Vaccines|April 3, 2020
Upper respiratory tract colonization with <i>Streptococcus pneumoniae</i> in adultsAdriano Arguedas, Krzysztof Trzciński, Katherine L O'Brien, et al.
PLOS Global Public Health|May 7, 2026
Evaluation and estimation of epidemic trajectories for SARS-CoV-2 from clinical and wastewater data in Gauteng Province, South AfricaZinhle E Mthombothi, Adrian Lison, Fiona Els, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
The Lancet Regional Health. Europe|August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort studyCatherine Hyams, Robert Challen, Elizabeth Begier, et al.
Journal of the International AIDS Society|July 24, 2018
Estimating the contribution of key populations towards the spread of HIV in Dakar, SenegalChristinah Mukandavire, Josephine Walker, Sheree Schwartz, et al.
BJGP Open|September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
The Journal of Infection|June 19, 2022
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adultsRajeka Lazarus, Christian Taucher, Claire Brown, et al.
Pageof 7